28 April 2026 · By Dr Sadhna Singhal Vishnoi

Menopause Management in Delhi: Hormone Therapy, Bone Health, and Beyond

The average age of menopause in India is 46-48 — and many women experience perimenopausal symptoms from their early 40s. Dr Sadhna's guide to managing this important life transition with hormone therapy, lifestyle, and clinical monitoring.

Menopause Management in Delhi: Hormone Therapy, Bone Health, and Beyond

Menopause is not a disease — it is a natural life transition. But the perimenopausal and postmenopausal years bring significant changes in physical and emotional health that deserve attention, evaluation, and where appropriate, treatment. In India, the average age of menopause is 46-48 years — earlier than in Western populations. Perimenopausal symptoms can begin 5-10 years before final menstruation: irregular cycles, hot flashes, night sweats, sleep disturbance, mood changes, vaginal dryness, weight gain, and reduced libido. Postmenopause brings additional concerns: accelerated bone density loss (osteoporosis risk), increased cardiovascular risk, and changes in skin, hair, and cognitive function. Dr Sadhna's approach to menopause care begins with a thorough evaluation: hormonal panel (FSH, estradiol, thyroid), bone density scan (DEXA), lipid profile, and cardiac risk assessment. Symptoms are assessed using validated questionnaires to understand severity and impact on quality of life. Treatment is individualised based on symptom severity and personal risk profile. For mild to moderate symptoms: lifestyle interventions take priority — calcium and vitamin D supplementation, weight-bearing exercise, balanced diet rich in phytoestrogens (soy, flaxseed), adequate sleep, and stress reduction. For moderate to severe symptoms affecting quality of life: hormone replacement therapy (HRT) is considered after careful risk-benefit assessment. Modern HRT — when prescribed at the lowest effective dose, for the shortest necessary duration, and with regular monitoring — is safe and highly effective for the majority of women. Dr Sadhna assesses individual contraindications carefully: family history of breast cancer, personal history of venous thromboembolism, severe liver disease, or known oestrogen-dependent cancer. For women in whom systemic HRT is contraindicated, local vaginal oestrogen, non-hormonal medications, or alternative therapies are available. Beyond symptom management, postmenopausal women require structured long-term monitoring: annual cardiovascular risk assessment, bone density scanning every 2 years, breast and cervical cancer screening as per guidelines, and counselling on sexual and emotional wellness. If you are experiencing perimenopausal symptoms in Delhi NCR or are planning your postmenopausal health strategy, Dr Sadhna offers comprehensive menopause consultations at SRV Clinic Paschim Vihar — focused on evidence-based individualised care rather than one-size-fits-all approaches.

#Menopause#Perimenopause#Hormone Therapy#HRT#Women's Health#Delhi
Dr Sadhna Singhal Vishnoi
About the author
Dr Sadhna Singhal Vishnoi
MBBS · DGO · DNB (Obstetrics & Gynaecology) · Fellowship in Minimal Invasive Surgery, BEAMS Mumbai · Specialised IVF Training, South End Infertility Centre
Full profile →

Related reading

More from the clinic

Have a related question?

Book a consultation with the clinic — the doctors will give you an honest answer.

Pick a slot →